Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2010 1
2011 2
2012 5
2013 5
2020 1
2021 2
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Extensive calcification in adenocarcinoma of the lung: A case report.
Watanabe F, Adachi K, Ito K, Iwanaka S, Ohiwa A, Sakakura Y, Nishimura T, Naito M. Watanabe F, et al. Among authors: naito m. Thorac Cancer. 2020 Oct;11(10):3038-3042. doi: 10.1111/1759-7714.13637. Epub 2020 Sep 1. Thorac Cancer. 2020. PMID: 32869499 Free PMC article.
Efficacy and Safety of Amrubicin in Small Cell Carcinoma Previously Treated with Immune Checkpoint Inhibitors and Chemotherapy.
Nishimura T, Fujimoto H, Fujiwara T, Ito K, Fujiwara A, Yuda H, Itani H, Naito M, Kodama S, Yagi A, D'Alessandro VF, Yasuma T, Furuhashi K, Saiki H, Okano T, Tomaru A, Tanigawa M, D'Alessandro-Gabazza CN, Gabazza EC, Yoshida M, Hataji O, Ibata H, Kobayashi T. Nishimura T, et al. Among authors: naito m. Cancers (Basel). 2022 Aug 16;14(16):3953. doi: 10.3390/cancers14163953. Cancers (Basel). 2022. PMID: 36010946 Free PMC article.
Is the Efficacy of Adding Ramucirumab to Docetaxel Related to a History of Immune Checkpoint Inhibitors in the Real-World Clinical Practice?
Nishimura T, Fujimoto H, Okano T, Naito M, Tsuji C, Iwanaka S, Sakakura Y, Yasuma T, D'Alessandro-Gabazza CN, Oomoto Y, Gabazza EC, Kobayashi T, Ibata H. Nishimura T, et al. Among authors: naito m. Cancers (Basel). 2022 Jun 16;14(12):2970. doi: 10.3390/cancers14122970. Cancers (Basel). 2022. PMID: 35740634 Free PMC article.
Complete withdrawal of glucocorticoids after dupilumab therapy in allergic bronchopulmonary aspergillosis: A case report.
Nishimura T, Okano T, Naito M, Tsuji C, Iwanaka S, Sakakura Y, Yasuma T, Fujimoto H, D'Alessandro-Gabazza CN, Oomoto Y, Kobayashi T, Gabazza EC, Ibata H. Nishimura T, et al. Among authors: naito m. World J Clin Cases. 2021 Aug 16;9(23):6922-6928. doi: 10.12998/wjcc.v9.i23.6922. World J Clin Cases. 2021. PMID: 34447843 Free PMC article.
Eosinophils promote epithelial to mesenchymal transition of bronchial epithelial cells.
Yasukawa A, Hosoki K, Toda M, Miyake Y, Matsushima Y, Matsumoto T, Boveda-Ruiz D, Gil-Bernabe P, Nagao M, Sugimoto M, Hiraguchi Y, Tokuda R, Naito M, Takagi T, D'Alessandro-Gabazza CN, Suga S, Kobayashi T, Fujisawa T, Taguchi O, Gabazza EC. Yasukawa A, et al. Among authors: naito m. PLoS One. 2013 May 21;8(5):e64281. doi: 10.1371/journal.pone.0064281. Print 2013. PLoS One. 2013. PMID: 23700468 Free PMC article.
Efficacy of a novel class of RNA interference therapeutic agents.
Hamasaki T, Suzuki H, Shirohzu H, Matsumoto T, D'Alessandro-Gabazza CN, Gil-Bernabe P, Boveda-Ruiz D, Naito M, Kobayashi T, Toda M, Mizutani T, Taguchi O, Morser J, Eguchi Y, Kuroda M, Ochiya T, Hayashi H, Gabazza EC, Ohgi T. Hamasaki T, et al. Among authors: naito m. PLoS One. 2012;7(8):e42655. doi: 10.1371/journal.pone.0042655. Epub 2012 Aug 15. PLoS One. 2012. PMID: 22916145 Free PMC article.
Second-line therapy with first- or second-generation tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer patients with T790M-negative or unidentified mutation.
Nishimura T, Okano T, Naito M, Iwanaka S, Ohiwa A, Sakakura Y, Yasuma T, Fujimoto H, D'Alessandro-Gabazza CN, Oomoto Y, Kobayashi T, Gabazza EC, Ibata H. Nishimura T, et al. Among authors: naito m. Thorac Cancer. 2021 Apr;12(7):1067-1073. doi: 10.1111/1759-7714.13870. Epub 2021 Feb 14. Thorac Cancer. 2021. PMID: 33586356 Free PMC article.
Thrombin-activatable fibrinolysis inhibitor protects against acute lung injury by inhibiting the complement system.
Naito M, Taguchi O, Kobayashi T, Takagi T, D'Alessandro-Gabazza CN, Matsushima Y, Boveda-Ruiz D, Gil-Bernabe P, Matsumoto T, Chelakkot-Govindalayathil AL, Toda M, Yasukawa A, Hataji O, Morser J, Takei Y, Gabazza EC. Naito M, et al. Am J Respir Cell Mol Biol. 2013 Oct;49(4):646-53. doi: 10.1165/rcmb.2012-0454OC. Am J Respir Cell Mol Biol. 2013. PMID: 23721130
Community-acquired pneumonia and nursing home-acquired pneumonia in the very elderly patients.
Maruyama T, Gabazza EC, Morser J, Takagi T, D'Alessandro-Gabazza C, Hirohata S, Nakayama S, Ramirez AY, Fujiwara A, Naito M, Nishikubo K, Yuda H, Yoshida M, Takei Y, Taguchi O. Maruyama T, et al. Among authors: naito m. Respir Med. 2010 Apr;104(4):584-92. doi: 10.1016/j.rmed.2009.12.008. Epub 2010 Jan 8. Respir Med. 2010. PMID: 20060700 Free article.
18 results